ubde8ka120060811amended20070.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
<R>Amendment Number 1 to
FORM 8-K/A</R>
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 7, 2006
 
 
US BIODEFENSE, INC. 
(Exact name of Registrant as specified in charter)
 
 
Utah   000-31431   33-0052057
(State of Other Jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification No.)
 
 
375 South 6th Avenue        
City of Industry, California       91746
(Address of Principal Executive Offices)       (Zip Code)
 
 
Registrant’s telephone number, including area code:        (626) 961-8039     
 
13674 E. Valley Blvd.
  City of Industry, California 91746
(Former Name or Former Address, if Changed Since Last Report)


ITEM 2.01 COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS 
 
            On August 7, 2006, the Registrant entered into a Stock Purchase Agreement (“Agreement”) with Charles 
Wright and Emergency Disaster Systems, Inc., a California corporation (“EDS”), pursuant to which the Registrant 
acquired 1,000 shares of common stock of EDS (the “Shares”), which represents all of the issued and outstanding 
common stock of EDS, from Mr. Wright. Under the terms of the Agreement, the Registrant agreed to purchase the 
Shares for an aggregate of $25,000, paid in cash upon execution of the Agreement from the Registrant’s corporate 
checking account. As a result of the purchase of all of the issued and outstanding common stock of EDS, EDS will 
become a wholly-owned subsidiary of the Registrant. 
 
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS 
 
Exhibit     
Number    Name and/or Identification of Exhibit 
 
 
<R>2.1    Stock Purchase Agreement * 
 
 
 
10.1    Stock Purchase Agreement with Equity Solutions, Inc. * 
 
 
 
99.1    Financial Statements of Emergency Disaster Systems, Inc. 
 
 
 
*    Incorporated by reference herein to Form 8-K filed on August 14, 2006 </R> 


SIGNATURES
 
                   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.    
<R>        
US BIODEFENSE, INC.
(Registrant)
 
Signature   Title   Date
 
/s/ David Chin   President and CEO   February 20, 2007
David Chin        
 
/s/ David Chin   Secretary   February 20, 2007
David Chin        
 
/s/ David Chin   Principal Financial Officer   February 20, 2007
David Chin        
 
</R>